Dysthyroidism and Chronic Heart Failure: Pathophysiological Mechanisms and Therapeutic Approaches

Caterina Rizzo1, Margherita Ilaria Gioia1, Giuseppe Parisi1

  • 1School of Cardiology, University of Bari "Aldo Moro", Bari, Italy.

Insights

Thyroid dysfunction (dysthyroidism) is common in chronic heart failure (CHF) patients, impacting disease progression and outcomes. Prompt treatment is crucial for managing these complex cardiovascular comorbidities.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Thyroid dysfunction, or dysthyroidism, is a significant comorbidity in chronic heart failure (CHF) patients, particularly affecting the aging population.
  • Thyroid hormones critically influence cardiovascular function, and their imbalance can exacerbate CHF conditions.
  • Hypothyroidism is prevalent in CHF patients, affecting disease onset, progression, and prognosis, while hyperthyroidism, though less common, requires urgent intervention.

Purpose of the Study:

  • To analyze the prevalence of thyroid disorders in patients with chronic heart failure.
  • To elucidate the pathophysiology linking thyroid dysfunction and CHF.
  • To evaluate the prognostic impact of thyroid disorders on chronic heart failure outcomes.

Main Methods:

  • Review of the best available scientific evidence.
  • Analysis of cumulative clinical experience.
  • Examination of epidemiological data on dysthyroidism in CHF populations.

Main Results:

  • Dysthyroidism is a relevant comorbidity in chronic heart failure, especially in older patients.
  • Hypothyroidism plays a key role in CHF onset, progression, and prognosis.
  • Hyperthyroidism, though less frequent, has immediate negative cardiovascular effects, and iatrogenic dysthyroidism (e.g., from Amiodarone) is a consideration.

Conclusions:

  • Thyroid disorders represent a significant challenge in managing chronic heart failure patients.
  • Understanding the interplay between thyroid function and heart failure is essential for optimizing patient care and prognosis.
  • Clinical vigilance for dysthyroidism, including drug-induced cases, is vital in the chronic heart failure population.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
969
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
369
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
403
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
483